Your browser doesn't support javascript.
loading
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
Görgün, Güllü; Calabrese, Elisabetta; Hideshima, Teru; Ecsedy, Jeffrey; Perrone, Giulia; Mani, Mala; Ikeda, Hiroshi; Bianchi, Giada; Hu, Yiguo; Cirstea, Diana; Santo, Loredana; Tai, Yu-Tzu; Nahar, Sabikun; Zheng, Mei; Bandi, Madhavi; Carrasco, Ruben D; Raje, Noopur; Munshi, Nikhil; Richardson, Paul; Anderson, Kenneth C.
Affiliation
  • Görgün G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. gullu_gorgun@dfci.harvard.edu
Blood ; 115(25): 5202-13, 2010 Jun 24.
Article in En | MEDLINE | ID: mdl-20382844
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Azepines / Protein Serine-Threonine Kinases / Apoptosis / Protein Kinase Inhibitors / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2010 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Azepines / Protein Serine-Threonine Kinases / Apoptosis / Protein Kinase Inhibitors / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2010 Type: Article Affiliation country: United States